• LAST PRICE
    2.8000
  • TODAY'S CHANGE (%)
    Trending Down-0.0900 (-3.1142%)
  • Bid / Lots
    2.7700/ 1
  • Ask / Lots
    2.8000/ 2
  • Open / Previous Close
    2.9000 / 2.8900
  • Day Range
    Low 2.7700
    High 3.0400
  • 52 Week Range
    Low 2.4000
    High 75.0000
  • Volume
    213,050
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.89
TimeVolumeREVB
09:32 ET29592.9501
09:33 ET6002.99
09:35 ET20153.03
09:39 ET24522.9701
09:42 ET43512.995
09:44 ET31003
09:46 ET1003
09:50 ET11922.9999
09:51 ET1002.8952
09:53 ET28712.94
09:55 ET10002.97
09:57 ET63012.96
10:00 ET2002.9499
10:02 ET38882.945
10:04 ET5312.95
10:06 ET25142.9703
10:08 ET8002.9768
10:09 ET1892.97
10:11 ET2002.98
10:13 ET45032.92
10:15 ET5002.9328
10:27 ET10002.915
10:29 ET24302.9101
10:31 ET19662.91
10:33 ET3002.9483
10:36 ET10002.9027
10:40 ET3002.95
10:42 ET6262.93
10:45 ET6002.9099
10:47 ET3002.915
10:51 ET6762.93
10:56 ET2002.912
11:00 ET42472.9
11:02 ET3002.91
11:07 ET2142.94
11:12 ET6022.87
11:14 ET9002.87
11:20 ET13282.9
11:23 ET1002.915
11:25 ET10002.9299
11:30 ET42692.8701
11:34 ET9982.8999
11:39 ET1002.87
11:41 ET1002.87
11:45 ET3002.8799
11:52 ET8712.87
11:54 ET7582.85
11:57 ET1002.8998
11:59 ET47622.88
12:03 ET4452.89
12:12 ET1002.89
12:14 ET11992.88
12:21 ET1002.8898
12:28 ET2002.8898
12:30 ET2212.89
12:32 ET2672.8841
12:39 ET1002.8801
12:50 ET1582.882
12:57 ET20002.8801
01:00 ET32412.88
01:02 ET193102.8601
01:06 ET10002.8501
01:11 ET1002.9158
01:18 ET1002.87
01:20 ET13392.88
01:24 ET4592.87
01:26 ET13002.8535
01:31 ET5492.8923
01:33 ET19472.86
01:36 ET18482.86
01:38 ET5072.85
01:42 ET2092.85
01:44 ET2492.85
01:49 ET2002.85
01:51 ET2002.8501
01:54 ET77462.85
01:56 ET3532.86
02:00 ET4512.85
02:02 ET60152.79
02:03 ET1752.79
02:07 ET1152.8
02:09 ET2502.825
02:12 ET18142.825
02:16 ET16662.8549
02:36 ET1002.83
02:38 ET14712.8
02:39 ET18792.7999
02:41 ET9112.82
02:45 ET12332.8399
02:50 ET8892.8399
02:52 ET10872.84
02:54 ET9302.8399
02:56 ET1002.84
02:59 ET8922.84
03:03 ET59642.8101
03:06 ET20132.81
03:08 ET4002.81
03:10 ET9612.82
03:12 ET7502.8028
03:17 ET11002.8199
03:19 ET1502.8012
03:24 ET50402.8101
03:26 ET14222.8
03:35 ET4992.8
03:39 ET12502.815
03:44 ET1392.8
03:46 ET21002.8297
03:48 ET37912.83
03:50 ET5002.7999
03:51 ET64672.8099
03:53 ET6002.7801
03:55 ET7452.79
03:57 ET1002.7749
04:00 ET15062.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesREVB
Revelation Biosciences Inc
1.1M
-7.2x
---
United StatesCTTH
CTT Pharmaceutical Holdings Inc
1.1M
-0.3x
---
United StatesEVLO
Evelo Biosciences Inc
1.0M
0.0x
---
United StatesTHAR
Tharimmune Inc
939.5K
0.0x
---
United StatesLADX
LadRx Corp
925.8K
27.3x
---
United StatesZVSA
Zyversa Therapeutics Inc
1.3M
0.0x
---
As of 2024-02-24

Company Information

Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on the active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include REVTx-300, which is being developed as a potential therapy for the prevention and treatment of acute organ injury and chronic organ disease; REVTx-100, which is being developed for the prevention and treatment of infections, including healthcare-associated bacterial infections resulting from surgery, severe burns, and antibiotic resistance; REVTx-200, which is being developed as a potential intranasal therapy that is administered with a traditional commercially available intramuscular (IM) vaccine, and REVTx-99b, which is being developed as a treatment for food allergies.

Contact Information

Headquarters
4660 Lajolla Village Drive, Suite 100SAN DIEGO, CA, United States 92122
Phone
650-800-3717
Fax
302-645-1280

Executives

Independent Chairman of the Board
George Tidmarsh
Chief Executive Officer, Co-Founder, Director
James Rolke
Chief Financial Officer
Chester Zygmont
Independent Director
Jennifer Carver
Independent Director
Lakhmir Chawla

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.1M
Revenue (TTM)
$0.00
Shares Outstanding
396.4K
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.39
Book Value
$1.54
P/E Ratio
-7.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
1.2x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.